Male contraception

It takes both parties to create a baby.

Why should the responsibility fall on just one?

Medical issues limited my contraceptive choices.

Partners should have equal options for prevention.

Child support is no joke.

If I wasn't ready to have kids, I'd take birth control religiously.

40%

of pregnancies worldwide are unintended

23%

of the total contraceptive methods are targeted at men

50%

of US men would consider long-term reversible contraception

80%

Of US men feel sole or shared responsibility for pregnancy prevention

Sharing the
Burden of
Contraception

Contraception has largely been a woman’s responsibility, with men having few options beyond condoms or vasectomy. As shared birth control responsibility gains traction, demand for hormone-free, long-term, and reversible male contraception is growing –

17M men are looking for contraception that fits their lifestyle and relationship. The growing demand creates a huge market opportunity for innovative solutions such as Proventis.

Proventis^TM Solution

The Safe & Reliable In-Office Solution

Minimally invasive male contraception in less than 20 minutes. Proventis develops the first reversible, long-term and reliable contraceptive device for men.

Implant is Inserted

Implant blocks sperm flow

Implant is opened

Sperm flows through the implant

Our Technology

The Proventis implant is inserted into the vas deferens using an approach similar to the gold-standard Non-Scalpel Vasectomy (NSV) technique. It blocks sperm flow from reaching the urethra for effective contraception and can be easily unplugged to restore fertility on demand. Both implantation and reversal are minimally invasive and performed by a urologist under local anesthesia in under 20 minutes.

Implant is Inserted

Proventis implant is inserted into each of the two vas deferens, using an approach similar to the gold-standard Non-Scalpel Vasectomy (NSV) technique. The procedure is performed by a urologist under local anesthesia in less than 20 minutes.

Implant blocks sperm flow

The implant serves as a plug that prevents sperm flow from the testicle to the urethra. The user is able to ejaculate as always, but the ejaculation does not contain sperm. Sperm cells are degraded and naturally absorbed.

Implant is opened

Upon user request, the physician opens the implant is a minimally invasive manner, under local anesthesia.

Sperm flows through the implant

As the implant becomes unplugged, sperm flow is regained. The ejaculate contains sperm cells, so fertility is restored.

Advantages

Reversal On-Demand

Allowing natural fertility to be restored when desired

Reliable & Long-Term

Provides effective contraception for years

Non-Hormonal

Eliminates the risks and side effects of hormonal contraception

Quick & Simple

Easily inserted and unplugged through in-office procedures taking less than 20 minutes

True Shared Responsibility

Provides men with reliable long-term contraception and active participation in family planning

Become a Partner

Interested in helping Proventis promote family planning equity?

ProventisTM vision
and team

Proventis was founded in 2025 by Bar Evyatar and Netta Hirshberg to offer couples a groundbreaking alternative to the currently available contraception methods.

Our goal is to revolutionize male contraception with a reliable, long-term yet reversible device that addresses a major gap in male reproductive health. We believe that our device will empower couples with shared responsibility in family planning.

Bar Evyatar

Co-Founder, CEO

Bar is a seasoned mechanical engineer and project manager with over a decade of experience in the medical device industry, particularly in cardiovascular projects. He has expertise in R&D, regulatory affairs, product management, and clinical affairs. Bar is also a member in two Boards of Directors, managing multidisciplinary projects. Bar holds a B.Sc. in Mechanical Engineering.

Netta Hirshberg

Co-Founder, COO

Netta has extensive managerial experience in the medical device industry, including AV Medical (acquired by Medtronic) and Pristine (acquired by Bard). In her various roles, Netta steered processes related to the full product lifecycle: from ideation to commercial sales and acquisition. Netta holds an M.Sc. in Biotechnology Engineering and an MBA.

ProventisTM Solution